Empowered Funds
LUNG icon

Empowered Funds’s Pulmonx LUNG Stock Holding History

Empowered Funds’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$66.2K Buy
+34,655
New +$65.3K ﹤0.01% 2452

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Empowered Funds's LUNG Position: Q3 2026 in Review

Empowered Funds opened a new position in Pulmonx (LUNG) in Q3 2026: 34,655 shares worth $66.2K. The stake represents ﹤0.01% of the portfolio and ranks #2452 among its holdings.

72 funds tracked by Wall St. Rank hold LUNG as of Q3 2026.

  • Empowered Funds held 34,655 shares of Pulmonx worth $66.2K as of Q3 2026.
  • Pulmonx was a new Empowered Funds position in Q3 2026.
  • Pulmonx made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2452 holding.
  • 72 funds tracked by Wall St. Rank held Pulmonx as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.